{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:45:11Z","timestamp":1791042311066,"version":"4.1.0"},"publisher-location":"Chichester, UK","reference-count":110,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd003160.pub2","type":"reference-entry","created":{"date-parts":[[2009,4,15]],"date-time":"2009-04-15T18:26:16Z","timestamp":1239819976000},"source":"Crossref","is-referenced-by-count":82,"title":["Statins for the prevention of dementia"],"prefix":"10.1002","author":[{"given":"Bernadette","family":"McGuinness","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Craig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Bullock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Passmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,4,15]]},"reference":[{"key":"10.1002\/14651858.CD003160.pub2-BIB1|cit1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial","volume":"360","year":"2002","journal-title":"The Lancet"},{"key":"10.1002\/14651858.CD003160.pub2-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1111\/j.1532-5415.2007.01415.x","article-title":"Association between apolipoprotein E4 and cognitive decline in elderly adults","volume":"11","author":"Packard","year":"2007","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1002\/14651858.CD003160.pub2-BIB4|cit3","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0140-6736(02)11600-X","article-title":"Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial","volume":"360","author":"Shepherd","year":"2002","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003160.pub2-BIB3|cit4","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/S0002-9149(99)00533-0","article-title":"The design of a prospective study of pravastatin in the elderly at risk (PROSPER)","volume":"84","author":"Shepherd","year":"1999","journal-title":"American Journal of Cardiology"},{"key":"10.1002\/14651858.CD003160.pub2-BIB5|cit5","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S0002-9343(00)00353-3","article-title":"Effects of Lovastatin on Cognitive Function and Psychological Well-being","volume":"108","author":"Muldoon","year":"2000","journal-title":"American Journal of Medicine"},{"key":"10.1002\/14651858.CD003160.pub2-BIB6|cit6","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.amjmed.2004.07.041","article-title":"Randomized Trial of the Effects of Simvastatin on Cognitive Functioning in Hypercholesterolemic Adults","volume":"117","author":"Muldoon","year":"2004","journal-title":"American Journal of Medicine"},{"key":"10.1002\/14651858.CD003160.pub2-BIB7|cit7","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/archinte.1994.00420050081008","article-title":"Cholesterol lowering in the elderly. results of the cholesterol reduction in seniors program (CRISP) pilot study","volume":"154","author":"LaRosa","year":"1994","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD003160.pub2-BIB8|cit8","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1532-5415.1997.tb00971.x","article-title":"Effect of Pharmacologic Lipid Lowering on Health-Related Quality of Life in Older Persons: Results from the Cholesterol Reduction in Seniors program (CRISP) Pilot Study","volume":"45","author":"Santanello","year":"1997","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1002\/14651858.CD003160.pub2-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1212\/01.wnl.0000288181.00826.63","article-title":"Statins, incident alzheimer disease, change in cognitive function, and neuropathology","volume":"70","author":"Arvanitakis","year":"2008","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD003160.pub2-BIB10|cit10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000017215","article-title":"Neuropathological substrates of dementia and depression in vascular dementia, with a particular focus on cases with small infarct volumes","volume":"11","author":"Ballard","year":"2000","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"key":"10.1002\/14651858.CD003160.pub2-BIB11|cit11","first-page":"427","article-title":"Brain and optic system pathology in hypocholesterolemic dogs treated with a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase","volume":"132","author":"Berry","year":"1988","journal-title":"American Journal of Pathology"},{"key":"10.1002\/14651858.CD003160.pub2-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/S0022-2275(20)32188-X","article-title":"Cholesterol homeostasis in human brain: Turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation","volume":"39","author":"Bjorkhem","year":"1998","journal-title":"Journal of Lipid Research"},{"key":"10.1002\/14651858.CD003160.pub2-BIB13|cit13","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/00041433-199904000-00010","article-title":"Removal of cholesterol from extrahepatic sources by oxidative mechanisms","volume":"10","author":"Bjorkhem","year":"1999","journal-title":"Current Opinion in Lipidology"},{"key":"10.1002\/14651858.CD003160.pub2-BIB14|cit14","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1161\/01.STR.0000091396.95360.E1","article-title":"Efficacy and tolerability of donepezil in vascular dementia: Positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial","volume":"34","author":"Black","year":"2003","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD003160.pub2-BIB15|cit15","doi-asserted-by":"crossref","first-page":"4436","DOI":"10.1074\/jbc.271.8.4436","article-title":"Cholesterol modulates alpha-secretase cleavage of amyloid precursor protein","volume":"271","author":"Bodovitz","year":"1996","journal-title":"Journal of Biological Chemistry"},{"key":"10.1002\/14651858.CD003160.pub2-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1212\/WNL.44.7.1246","article-title":"Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: The Rotterdam study","volume":"44","author":"Breteler","year":"1994","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD003160.pub2-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.2105\/AJPH.88.9.1337","article-title":"Projections of Alzheimer\u2019s disease in the united states and the public health impact of delaying disease onset","volume":"88","author":"Brookmeyer","year":"1998","journal-title":"American Journal of Public Health"},{"key":"10.1002\/14651858.CD003160.pub2-BIB18|cit18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0169-328X(02)00647-2","article-title":"Co-localization of cholesterol, apolipoprotein E and fibrillar abeta in amyloid plaques","volume":"110","author":"Burns","year":"2003","journal-title":"Brain Research. Molecular Brain Research"},{"key":"10.1002\/14651858.CD003160.pub2-BIB19|cit19","unstructured":"CLASP Cholesterol lowering agent to slow progression of Alzheimer's disease study Clinical Trials.gov, National Institutes of Health\/National Library of Medicine Web site. Available at http:\/\/www.clinicaltrials.gov\/show\/NCT00053599"},{"key":"10.1002\/14651858.CD003160.pub2-BIB20|cit20","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1161\/01.ATV.15.11.1987","article-title":"High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules","volume":"15","author":"Cockerill","year":"1995","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1002\/14651858.CD003160.pub2-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1096\/fj.01-0075com","article-title":"High density lipoproteins reduce organ injury and organ dysfunction in a rat model of hemorrhagic shock","volume":"15","author":"Cockerill","year":"2001","journal-title":"FASEB Journal"},{"key":"10.1002\/14651858.CD003160.pub2-BIB22|cit22","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1750-1326-2-22","article-title":"The alzheimer's disease beta-secretase enzyme, BACE1","volume":"2","author":"Cole","year":"2007","journal-title":"Molecular Neurodegeneration"},{"key":"10.1002\/14651858.CD003160.pub2-BIB23|cit23","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of alzheimer's disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Sceince"},{"key":"10.1002\/14651858.CD003160.pub2-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: Prospective meta-analysis of data from 90,056 participants in 14 randomized trials of statins","volume":"366","year":"2005","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003160.pub2-BIB25|cit25","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1749-6632.2002.tb04802.x","article-title":"Paraoxonase 1 activity: A new vascular marker of dementia?","volume":"977","author":"Dantoine","year":"2002","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1002\/14651858.CD003160.pub2-BIB26|cit26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jns.2004.09.005","article-title":"Vascular factors in dementia: An overview","volume":"226","author":"Decarli","year":"2004","journal-title":"Journal of Neurological Science"},{"key":"10.1002\/14651858.CD003160.pub2-BIB27|cit27","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1212\/01.WNL.0000160114.42643.31","article-title":"APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: The three-city study","volume":"64","author":"Dufouil","year":"2005","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD003160.pub2-BIB28|cit28","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1083\/jcb.200207113","article-title":"Amyloidogenic processing of the alzheimer beta-amyloid precursor protein depends on lipid rafts","volume":"160","author":"Ehehalt","year":"2003","journal-title":"Journal of Cell Biology"},{"key":"10.1002\/14651858.CD003160.pub2-BIB29|cit29","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/01.psy.0000151745.67285.c2","article-title":"Serum cholesterol and cognitive performance in the Framingham Heart Study","volume":"67","author":"Elias","year":"2005","journal-title":"Psychosomatic Medicine"},{"key":"10.1002\/14651858.CD003160.pub2-BIB30|cit30","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/jnnp.63.6.749","article-title":"Neuropathological assessment of the lesions of significance in vascular dementia","volume":"63","author":"Esiri","year":"1997","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD003160.pub2-BIB31|cit31","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1399-0004.1988.tb02871.x","article-title":"Apolipoprotein E alleles and hyperlipoproteinemia in Japan","volume":"34","author":"Eto","year":"1988","journal-title":"Clinical Genetics"},{"key":"10.1002\/14651858.CD003160.pub2-BIB32|cit32","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","article-title":"Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and alzheimer disease. A meta-analysis. APOE and alzheimer disease meta analysis consortium","volume":"278","author":"Farrer","year":"1997","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD003160.pub2-BIB33|cit33","doi-asserted-by":"crossref","first-page":"5856","DOI":"10.1073\/pnas.081620098","article-title":"Simvastatin strongly reduces levels of alzheimer's disease B-amyloid peptides AB42 and AB40 in vitro and in vivo","volume":"98","author":"Fassbender","year":"2001","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1002\/14651858.CD003160.pub2-BIB34|cit34","series-title":"Neurology","first-page":"153","article-title":"The LEADe study: A randomized controlled trial investigating the effect of atorvastatin on cognitive and global function in patients with mild-to-moderate Alzheimer's disease receiving background therapy of donepezil","author":"Feldman"},{"key":"10.1002\/14651858.CD003160.pub2-BIB35|cit35","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","article-title":"Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein","volume":"20","author":"Glenner","year":"1984","journal-title":"Biochemistry Biophysics Research Communications"},{"key":"10.1002\/14651858.CD003160.pub2-BIB36|cit36","doi-asserted-by":"crossref","first-page":"M414","DOI":"10.1093\/gerona\/57.7.M414","article-title":"The impact of the use of statins on the prevalence of dementia and the progression of cognitive impairment","volume":"57","author":"Hajjar","year":"2002","journal-title":"Journal of Gerontology A Biological Science Medical Science"},{"key":"10.1002\/14651858.CD003160.pub2-BIB37|cit37","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1001\/archneur.57.10.1410","article-title":"Is there a connection between the concentration of cholesterol circulating in plasma and the rate of neuritic plaque formation in Alzheimer's disease","volume":"57","author":"Haley","year":"2000","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD003160.pub2-BIB38|cit38","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.plefa.2004.06.001","article-title":"Statin treatment alters serum n-3 and n-6 fatty acids in hypercholesterolemic patients","volume":"71","author":"Harris","year":"2004","journal-title":"Prostaglandins, Leukotrienes and Essential Fatty Acids"},{"key":"10.1002\/14651858.CD003160.pub2-BIB39|cit39","doi-asserted-by":"crossref","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008] The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org","DOI":"10.1002\/9780470712184"},{"key":"10.1002\/14651858.CD003160.pub2-BIB40|cit40","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/1531-8249(200006)47:6<739::AID-ANA6>3.0.CO;2-8","article-title":"Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model","volume":"47","author":"Holtzman","year":"2000","journal-title":"Annals of Neurology"},{"key":"10.1002\/14651858.CD003160.pub2-BIB41|cit41","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1212\/WNL.45.6.1092","article-title":"Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease: a case control study","volume":"45","author":"Jarvik","year":"1995","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD003160.pub2-BIB42|cit42","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(00)03155-X","article-title":"Statins and the risk of dementia","volume":"356","author":"Jick","year":"2000","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003160.pub2-BIB43|cit43","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jalz.2008.02.001","article-title":"The Atorvastatin\/Donepezil in Alzheimer's Disease Study (LEADe): Design and baseline characteristics","volume":"4","author":"Jones","year":"2008","journal-title":"Alzheimer's & Dementia"},{"key":"10.1002\/14651858.CD003160.pub2-BIB44|cit44","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1592\/phco.23.15.1663.31953","article-title":"Cognitive impairment associated with atorvastatin and simvastatin","volume":"23","author":"King","year":"2003","journal-title":"Pharmacotherapy"},{"issue":"3","key":"10.1002\/14651858.CD003160.pub2-BIB45|cit45","doi-asserted-by":"crossref","first-page":"149","DOI":"10.7326\/0003-4819-137-3-200208060-00006","article-title":"Apolipprotein E e4 Allele, elevated midlife total cholesterol level, and high midlife systolic blood presure are independent risk factors for late-life Alzheimer's disease","volume":"137","author":"Kivipelto","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD003160.pub2-BIB46|cit46","first-page":"269","article-title":"Vascular dementia and systemic changes","volume":"59","author":"Klich-Raczka","year":"2002","journal-title":"Przegl. Lek"},{"key":"10.1002\/14651858.CD003160.pub2-BIB47|cit47","first-page":"589","article-title":"Low levels of serum apolipoprotein A I and A II in senile dementia","volume":"48","author":"Kuriyama","year":"1994","journal-title":"Japanese Journal of Psychiatry and Neurology"},{"key":"10.1002\/14651858.CD003160.pub2-BIB48|cit48","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1016\/S0022-2275(20)32101-5","article-title":"Regulation of endoplasmic reticulum cholesterol by plasma membrane cholesterol","volume":"40","author":"Lange","year":"1999","journal-title":"Journal of Lipid Research"},{"key":"10.1002\/14651858.CD003160.pub2-BIB49|cit49","unstructured":"Leade PfizerStudies.com. http:\/\/secure1.acuiantrials.com\/jsp\/pfizer_leade"},{"key":"10.1002\/14651858.CD003160.pub2-BIB50|cit50","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1212\/01.WNL.0000142963.90204.58","article-title":"Statin therapy and risk of dementia in the elderly: A community-based prospective cohort study","volume":"63","author":"Li","year":"2004","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD003160.pub2-BIB51|cit51","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1212\/01.wnl.0000277657.95487.1c","article-title":"Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease","volume":"69","author":"Li","year":"2007","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD003160.pub2-BIB52|cit52","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1172\/JCI0216421","article-title":"Isoprenoids as mediators of the biological effects of statins","volume":"110","author":"Liao","year":"2002","journal-title":"Journal of Clinical Investigation"},{"key":"10.1002\/14651858.CD003160.pub2-BIB53|cit53","doi-asserted-by":"crossref","first-page":"9799","DOI":"10.1073\/pnas.93.18.9799","article-title":"Cholesterol homeostasis in human brain: Evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation","volume":"93","author":"Lutjohann","year":"1996","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1002\/14651858.CD003160.pub2-BIB54|cit54","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0022-2275(20)32052-6","article-title":"Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in alzheimer and vascular demented patients","volume":"41","author":"Lutjohann","year":"2000","journal-title":"Journal of Lipid Research"},{"key":"10.1002\/14651858.CD003160.pub2-BIB55|cit55","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1023\/A:1023211323853","article-title":"APP processing enzymes (secretases) as therapeutic targets: Insights from the use of transgenics (tgs) and transfected cells","volume":"28","author":"Marks","year":"2003","journal-title":"Neurochemistry Research"},{"key":"10.1002\/14651858.CD003160.pub2-BIB56|cit56","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1126\/science.294.5545.1354","article-title":"CNS synaptogenesis promoted by glia-derived cholesterol","volume":"294","author":"Mauch","year":"2001","journal-title":"Science"},{"issue":"1","key":"10.1002\/14651858.CD003160.pub2-BIB57|cit57","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007514","article-title":"Statins for the treatment of Alzheimer's disease and dementia","author":"McGuinness","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003160.pub2-BIB58|cit58","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/(SICI)1097-4547(19981001)54:1<58::AID-JNR7>3.0.CO;2-G","article-title":"E4 induces neuronal cell death under conditions of suppressed de novo cholesterol synthesis","volume":"54","author":"Michikawa","year":"1998","journal-title":"Journal of Neuroscience Research"},{"key":"10.1002\/14651858.CD003160.pub2-BIB59|cit59","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1345\/aph.1D104","article-title":"The role of cholesterol and statins in alzheimer's disease","volume":"38","author":"Miller","year":"2004","journal-title":"Annals of Pharmacotherapy"},{"key":"10.1002\/14651858.CD003160.pub2-BIB60|cit60","doi-asserted-by":"crossref","first-page":"15110","DOI":"10.1074\/jbc.274.21.15110","article-title":"Cholesterol-dependent generation of a seeding amyloid beta-protein in cell culture","volume":"274","author":"Mizuno","year":"1999","journal-title":"Journal of Biological Chemistry"},{"key":"10.1002\/14651858.CD003160.pub2-BIB61|cit61","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1001\/jama.282.3.254","article-title":"Low-density lipoprotein cholesterol and the risk of dementia with stroke","volume":"282","author":"Moroney","year":"1999","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD003160.pub2-BIB62|cit62","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(85)92866-1","article-title":"High-density lipoprotein cholesterol in differential diagnosis of senile dementia","volume":"1","author":"Muckle","year":"1985","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003160.pub2-BIB63|cit63","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/00006842-199707000-00008","article-title":"Serum cholesterol and intellectual performance","volume":"59","author":"Muldoon","year":"1997","journal-title":"Psychosomatic Medicine"},{"key":"10.1002\/14651858.CD003160.pub2-BIB64|cit64","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0896-6273(95)90079-9","article-title":"Characterization of stable complexes involving apolipoprotein E and the amyloid beta peptide in alzheimer's disease brain","volume":"15","author":"Naslund","year":"1995","journal-title":"Neuron"},{"key":"10.1002\/14651858.CD003160.pub2-BIB65|cit65","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000026149","article-title":"Serum total cholesterol, apoliprotein E e4 allele, and Alzheimer's disease","volume":"17","author":"Notkola","year":"1998","journal-title":"Neuroepidemiology"},{"key":"10.1002\/14651858.CD003160.pub2-BIB66|cit66","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1016\/S0140-6736(97)07541-7","article-title":"Smoking and risk of dementia and alzheimer's disease in a population-based cohort study: The rotterdam study","volume":"351","author":"Ott","year":"1998","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003160.pub2-BIB67|cit67","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s00018-005-5406-7","article-title":"Lipid-lowering drugs","volume":"63","author":"Pahan","year":"2006","journal-title":"Cell Mol. Life Sci"},{"key":"10.1002\/14651858.CD003160.pub2-BIB68|cit68","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0014-5793(97)00609-1","article-title":"Enhanced oxidizability of ubiquinol and alpha-tocopherol during lovastatin treatment","volume":"410","author":"Palomaki","year":"1997","journal-title":"FEBS Letters"},{"key":"10.1002\/14651858.CD003160.pub2-BIB69|cit69","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s004060200013","article-title":"Serum paraoxonase activity changes in patients with alzheimer's disease and vascular dementia","volume":"252","author":"Paragh","year":"2002","journal-title":"European Archives of Psychiatry and Clinical Neuroscience"},{"key":"10.1002\/14651858.CD003160.pub2-BIB70|cit70","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1212\/WNL.58.8.1175","article-title":"The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function","volume":"58","author":"Posner","year":"2002","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD003160.pub2-BIB71|cit71","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1001\/archneur.62.7.1047","article-title":"Statin use and the risk of incident dementia: The cardiovascular health study","volume":"62","author":"Rea","year":"2005","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD003160.pub2-BIB72|cit72","first-page":"321","article-title":"Hypercholesterolemia accelerates the alzheimer's amyloid pathology in a transgenic mouse model","volume":"7","author":"Refolo","year":"2000","journal-title":"Neurobiological Disorders"},{"key":"10.1002\/14651858.CD003160.pub2-BIB73|cit73","first-page":"890","article-title":"A cholesterol-lowering drug reduces beta-amyloid pathology in a transgenic mouse model of alzheimer's disease","volume":"8","author":"Refolo","year":"2001","journal-title":"Neurobiological Disorders"},{"key":"10.1002\/14651858.CD003160.pub2-BIB74|cit74","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1582-4934.2007.00054.x","article-title":"Alzheimer's disease: Cholesterol, membrane rafts, isoprenoids and statins","volume":"11","author":"Reid","year":"2007","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"10.1002\/14651858.CD003160.pub2-BIB75|cit75","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1001\/archneur.61.5.705","article-title":"Relation of plasma lipids to alzheimer disease and vascular dementia","volume":"61","author":"Reitz","year":"2004","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD003160.pub2-BIB76|cit76","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S0022-2275(20)37414-9","article-title":"Effects of simvastatin on the metabolism of polyunsaturated fatty acids and on glycerolipid, cholesterol, and de novo lipid synthesis in THP-1 cells","volume":"38","author":"Rise","year":"1997","journal-title":"Journal of Lipid Research"},{"key":"10.1002\/14651858.CD003160.pub2-BIB77|cit77","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/archneur.59.2.223","article-title":"Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people","volume":"59","author":"Rockwood","year":"2002","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD003160.pub2-BIB78|cit78","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1046\/j.1532-5415.2002.50515.x","article-title":"Use of lipid-lowering drugs in older adults with and without dementia: A community-based epidemiological study","volume":"50","author":"Rodriguez","year":"2002","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1002\/14651858.CD003160.pub2-BIB79|cit79","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1046\/j.1532-5415.2002.50631.x","article-title":"New possible role of statins in age-related diseases","volume":"50","author":"Ruocco","year":"2002","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1002\/14651858.CD003160.pub2-BIB80|cit80","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0022-510X(02)00290-3","article-title":"Plasma antioxidant activity and vascular dementia","volume":"203-204","author":"Ryglewicz","year":"2002","journal-title":"Journal of Neurological Sciences"},{"key":"10.1002\/14651858.CD003160.pub2-BIB81|cit81","series-title":"Alzheimer's & Dementia","first-page":"T200","article-title":"Multi-centre, randomised, double-blind, placebo-controlled trial of simvastatin to slow the progression of Alzheimer's disease","author":"Sano","year":"2008"},{"key":"10.1002\/14651858.CD003160.pub2-BIB82|cit82","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1161\/01.ATV.14.7.1098","article-title":"Associations of lipoprotein cholesterols, apolipoproteins A-I and B, and triglycerides with carotid atherosclerosis and coronary heart disease. the atherosclerosis risk in communities (ARIC) study","volume":"14","author":"Sharrett","year":"1994","journal-title":"Arteriosclerosis and Thrombosis"},{"key":"10.1002\/14651858.CD003160.pub2-BIB83|cit83","doi-asserted-by":"crossref","first-page":"6460","DOI":"10.1073\/pnas.95.11.6460","article-title":"Cholesterol depletion inhibits the generation of B-amyloid in hippocampal neurons","volume":"95","author":"Simons","year":"1998","journal-title":"Proceedings of the National Academy of Sciences of USA"},{"key":"10.1002\/14651858.CD003160.pub2-BIB84|cit84","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1212\/WNL.57.6.1089","article-title":"Cholesterol and alzheimer's disease: Is there a link?","volume":"57","author":"Simons","year":"2001","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD003160.pub2-BIB85|cit85","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000026147","article-title":"Status of risk factors for vascular dementia","volume":"17","author":"Skoog","year":"1998","journal-title":"Neuroepidemiology"},{"key":"10.1002\/14651858.CD003160.pub2-BIB86|cit86","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jama.1997.03540340047031","article-title":"Brain infarction and the clinical expression of alzheimer disease. the nun study","volume":"277","author":"Snowdon","year":"1997","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD003160.pub2-BIB87|cit87","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJMoa061894","article-title":"High-dose atorvastatin after stroke or transient ischaemic attack","volume":"355","year":"2006","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD003160.pub2-BIB88|cit88","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1006\/exnr.1994.1044","article-title":"Induction of alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol","volume":"126","author":"Sparks","year":"1994","journal-title":"Experimental Neurology"},{"key":"10.1002\/14651858.CD003160.pub2-BIB89|cit89","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1600-0404.2006.00690.x","article-title":"Circulating cholesterol levels, apolipoprotein E genotype and dementia severity influence the benefit of atorvastatin treatment in alzheimer's disease: Results of the alzheimer's disease cholesterol-lowering treatment (ADCLT) trial","volume":"185","author":"Sparks","year":"2006","journal-title":"Acta Neurologica Scandinavica. Supplementum"},{"key":"10.1002\/14651858.CD003160.pub2-BIB90|cit90","doi-asserted-by":"crossref","first-page":"416","DOI":"10.2174\/156720508785132316","article-title":"Reduced Risk of Incident AD with Elective Statin Use in a Clinical Trial Cohort","volume":"5","author":"Sparks","year":"2008","journal-title":"Current Alzheimer Research"},{"key":"10.1002\/14651858.CD003160.pub2-BIB91|cit91","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1046\/j.1464-5491.1999.00027.x","article-title":"Type 2 diabetes mellitus, cognitive impairment and dementia","volume":"16","author":"Stewart","year":"1999","journal-title":"Diabetic Medicine"},{"key":"10.1002\/14651858.CD003160.pub2-BIB92|cit92","doi-asserted-by":"crossref","first-page":"8098","DOI":"10.1073\/pnas.90.17.8098","article-title":"Binding of human apolipoprotein E to synthetic amyloid beta peptide: Isoform-specific effects and implications for late-onset alzheimer disease","volume":"90","author":"Strittmatter","year":"1993","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1002\/14651858.CD003160.pub2-BIB93|cit93","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/71366","article-title":"Cholesterol binds to synaptophysin and is required for biogenesis of synaptic vesicles","volume":"2","author":"Thiele","year":"2000","journal-title":"Nature Cell Biology"},{"key":"10.1002\/14651858.CD003160.pub2-BIB94|cit94","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/ana.10220","article-title":"Association between high-density lipoprotein and cognitive impairment in the oldest old","volume":"51","author":"Exel","year":"2002","journal-title":"Annals of Neurology"},{"key":"10.1002\/14651858.CD003160.pub2-BIB95|cit95","doi-asserted-by":"crossref","first-page":"44945","DOI":"10.1074\/jbc.M407986200","article-title":"Association of gamma-secretase with lipid rafts in post-golgi and endosome membranes","volume":"279","author":"Vetrivel","year":"2004","journal-title":"Journal of Biological Chemistry"},{"key":"10.1002\/14651858.CD003160.pub2-BIB96|cit96","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1212\/01.wnl.0000192107.17175.39","article-title":"Amyloidogenic processing of beta-amyloid precursor protein in intracellular compartments","volume":"66","author":"Vetrivel","year":"2006","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD003160.pub2-BIB97|cit97","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1592\/phco.23.7.871.32720","article-title":"Statin-associated memory loss: Analysis of 60 case reports and review of the literature","volume":"23","author":"Wagstaff","year":"2003","journal-title":"Pharmacotherapy"},{"key":"10.1002\/14651858.CD003160.pub2-BIB98|cit98","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1177\/019262339602400409","article-title":"Subchronic toxicity of atorvastatin, a hydroxymethylglutaryl-coenzyme A reductase inhibitor, in beagle dogs","volume":"24","author":"Walsh","year":"1996","journal-title":"Toxicologic Pathology"},{"key":"10.1002\/14651858.CD003160.pub2-BIB99|cit99","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1161\/01.HYP.37.6.1450","article-title":"HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species","volume":"37","author":"Wassmann","year":"2001","journal-title":"Hypertension"},{"key":"10.1002\/14651858.CD003160.pub2-BIB100|cit100","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1212\/01.WNL.0000078943.50032.FC","article-title":"Donepezil in vascular dementia: A randomized, placebo-controlled study","volume":"61","author":"Wilkinson","year":"2003","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD003160.pub2-BIB101|cit101","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0140-6736(95)90701-7","article-title":"Is alzheimer's disease an apolipoprotein E amyloidosis?","volume":"345","author":"Wisniewski","year":"1995","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003160.pub2-BIB102|cit102","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1001\/archneur.57.10.1439","article-title":"Decreased prevalence of Alzhiemer's disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors","volume":"57","author":"Wolozin","year":"2000","journal-title":"Archives of Neurology"},{"issue":"20","key":"10.1002\/14651858.CD003160.pub2-BIB103|cit103","first-page":"1741","article-title":"Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease","volume":"5","author":"Wolozin","year":"2007","journal-title":"BMC Medicine"},{"key":"10.1002\/14651858.CD003160.pub2-BIB104|cit104","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1001\/archneur.59.3.378","article-title":"Serum lipoprotein levels, statin use, and cognitive function in older women","volume":"59","author":"Yaffe","year":"2002","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD003160.pub2-BIB105|cit105","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1212\/WNL.45.6.1161","article-title":"Incidence and risk factors of vascular dementia dn Alzheimer's disease in a defined elderly Japanese population: The Hisayama study","volume":"45","author":"Yoshitake","year":"1995","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD003160.pub2-BIB106|cit106","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000073981","article-title":"Association between statin use and alzheimer's disease","volume":"23","author":"Zamrini","year":"2004","journal-title":"Neuroepidemiology"},{"key":"10.1002\/14651858.CD003160.pub2-BIB107|cit107","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/archpsyc.62.2.217","article-title":"Do statins reduce risk of incident dementia and alzheimer disease? the cache county study","volume":"62","author":"Zandi","year":"2005","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD003160.pub2-BIB108|cit108","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/ajcn\/80.2.291","article-title":"Serum cholesterol concentrations are associated with visuomotor speed in men: Findings from the third national health and nutrition examination survey, 1988-1994","volume":"80","author":"Zhang","year":"2004","journal-title":"Americal Journal of Clinical Nutrition"},{"key":"10.1002\/14651858.CD003160.pub2-BIB109|cit109","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2318-1-5","article-title":"Lipoprotein profile in older patients with vascular dementia and alzheimer's disease","volume":"1","author":"Zuliani","year":"2001","journal-title":"BMC Geriatrics"},{"issue":"3","key":"10.1002\/14651858.CD003160.pub2-BIB110|cit110","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003160","article-title":"Statins for the prevention of Alzheimer's disease","author":"Scott","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd003160.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2016,1,4]],"date-time":"2016-01-04T00:00:00Z","timestamp":1451865600000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD003160.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T05:09:40Z","timestamp":1633324180000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD003160.pub2"}},"subtitle":[],"editor":[{"given":"Bernadette","family":"McGuinness","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2009,4,15]]},"references-count":110,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003160.pub2","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD003160.pub3","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2009,4,15]]}}}